126 related articles for article (PubMed ID: 29549749)
41. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
42. Hsp60, amateur chaperone in amyloid-beta fibrillogenesis.
Mangione MR; Vilasi S; Marino C; Librizzi F; Canale C; Spigolon D; Bucchieri F; Fucarino A; Passantino R; Cappello F; Bulone D; San Biagio PL
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2474-2483. PubMed ID: 27474204
[TBL] [Abstract][Full Text] [Related]
43. Chitosan Acetylation Degree Influences the Physical Properties of Polysaccharide Nanoparticles: Implication for the Innate Immune Cells Response.
Furlani F; Sacco P; Decleva E; Menegazzi R; Donati I; Paoletti S; Marsich E
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9794-9803. PubMed ID: 30768897
[TBL] [Abstract][Full Text] [Related]
44. Functionalization of gold nanoparticles with amino acid, beta-amyloid peptides and fragment.
Majzik A; Fülöp L; Csapó E; Bogár F; Martinek T; Penke B; Bíró G; Dékány I
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):235-41. PubMed ID: 20674288
[TBL] [Abstract][Full Text] [Related]
45. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
46. Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
Le Droumaguet B; Souguir H; Brambilla D; Verpillot R; Nicolas J; Taverna M; Couvreur P; Andrieux K
Int J Pharm; 2011 Sep; 416(2):453-60. PubMed ID: 21251960
[TBL] [Abstract][Full Text] [Related]
47. Influence of end-capping on the self-assembly of model amyloid peptide fragments.
Castelletto V; Hamley IW; Cenker Ç; Olsson U; Adamcik J; Mezzenga R; Miravet JF; Escuder B; Rodríguez-Llansola F
J Phys Chem B; 2011 Mar; 115(9):2107-16. PubMed ID: 21309578
[TBL] [Abstract][Full Text] [Related]
48. The aggregation of aβ42 induced by nano copper and the antagonistic action of polysaccharides.
Wang W; Zhang G; Zou J
Appl Biochem Biotechnol; 2015 Feb; 175(3):1557-66. PubMed ID: 25410807
[TBL] [Abstract][Full Text] [Related]
49. Structure, orientation, and surface interaction of Alzheimer amyloid-β peptides on the graphite.
Yu X; Wang Q; Lin Y; Zhao J; Zhao C; Zheng J
Langmuir; 2012 Apr; 28(16):6595-605. PubMed ID: 22468636
[TBL] [Abstract][Full Text] [Related]
50. Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process.
Mirsadeghi S; Dinarvand R; Ghahremani MH; Hormozi-Nezhad MR; Mahmoudi Z; Hajipour MJ; Atyabi F; Ghavami M; Mahmoudi M
Nanoscale; 2015 Mar; 7(11):5004-13. PubMed ID: 25695421
[TBL] [Abstract][Full Text] [Related]
51. Amyloid-β aggregation with gold nanoparticles on brain lipid bilayer.
Lee H; Kim Y; Park A; Nam JM
Small; 2014 May; 10(9):1779-89. PubMed ID: 24664514
[TBL] [Abstract][Full Text] [Related]
52. Protein L-isoaspartyl O-methyltransferase inhibits amyloid beta fibrillogenesis in vitro.
Jung G; Ryu J; Heo J; Lee SJ; Cho JY; Hong S
Pharmazie; 2011 Jul; 66(7):529-34. PubMed ID: 21812329
[TBL] [Abstract][Full Text] [Related]
53. Influence of Au nanoparticles on the aggregation of amyloid-β-(25-35) peptides.
Ma Q; Wei G; Yang X
Nanoscale; 2013 Nov; 5(21):10397-403. PubMed ID: 24056949
[TBL] [Abstract][Full Text] [Related]
54. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
55. HP-β-cyclodextrin as an inhibitor of amyloid-β aggregation and toxicity.
Ren B; Jiang B; Hu R; Zhang M; Chen H; Ma J; Sun Y; Jia L; Zheng J
Phys Chem Chem Phys; 2016 Jul; 18(30):20476-85. PubMed ID: 27405335
[TBL] [Abstract][Full Text] [Related]
56. A computational study of self-assembled hexapeptide inhibitors against amyloid-β (Aβ) aggregation.
Qiao Y; Zhang M; Liang Y; Zheng J; Liang G
Phys Chem Chem Phys; 2016 Dec; 19(1):155-166. PubMed ID: 27929168
[TBL] [Abstract][Full Text] [Related]
57. TANGO-Inspired Design of Anti-Amyloid Cyclic Peptides.
Lu X; Brickson CR; Murphy RM
ACS Chem Neurosci; 2016 Sep; 7(9):1264-74. PubMed ID: 27347598
[TBL] [Abstract][Full Text] [Related]
58. Aromaticity of Phenylalanine Residues Is Essential for Amyloid Formation by Alzheimer's Amyloid β-Peptide.
Genji M; Yano Y; Hoshino M; Matsuzaki K
Chem Pharm Bull (Tokyo); 2017; 65(7):668-673. PubMed ID: 28674340
[TBL] [Abstract][Full Text] [Related]
59. New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide.
Brambilla D; Verpillot R; Taverna M; De Kimpe L; Le Droumaguet B; Nicolas J; Canovi M; Gobbi M; Mantegazza F; Salmona M; Nicolas V; Scheper W; Couvreur P; Andrieux K
Anal Chem; 2010 Dec; 82(24):10083-9. PubMed ID: 21086977
[TBL] [Abstract][Full Text] [Related]
60. C-Terminal Fragment, Aβ32-37, Analogues Protect Against Aβ Aggregation-Induced Toxicity.
Bansal S; Maurya IK; Yadav N; Thota CK; Kumar V; Tikoo K; Chauhan VS; Jain R
ACS Chem Neurosci; 2016 May; 7(5):615-23. PubMed ID: 26835536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
